Positive Fit to Colonoscopy: Closing the Gap
Massachusetts General Hospital · with Robert Wood Johnson Foundation · NCT06763432
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 45
- US sites recruiting
- 1
- Study start
- June 16, 2025
- Record last updated
- November 13, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goals of this proposal are to: (1) identify patient- and system-level determinants of diagnostic colonoscopy after positive FIT; (2) identify patient- and system-level equity-driven implementation strategies for diagnostic colonoscopy after positive FIT matched to determinants; and (3) pilot test patient- and systems-level implementation strategies to increase rate of colonoscopy after positive FIT and determine feasibility and acceptability of strategies using mixed methods
Conditions: Colorectal Cancer Screening
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals aged 45-75
- Individuals who are patients at Codman Square Health Center
- Individuals that are willing and able to give verbal/written consent
Exclusion Criteria
- Individuals with a personal history of colorectal cancer
- Individuals with a family history of colorectal cancer
- Individuals with a history of inflammatory bowel disease or high-risk cancer syndrome
Recruiting US locations
Codman Square Health Center
Boston, MA 02124
Site contact: Stephen Tringale Dr. Tringale, MD, MA, FAAFP · 617-822-8260 · Stephen.Tringale@codman.org
Study contacts (from the official record)
- Adjoa Anyane-Yeboa, MD, MPH · 617-726-6609 · aanyane-yeboa@mgh.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+